Bristol-Myers Squibb Company (BMY)
NYSE
Closed
Oct 9, 2026
Day's Range
58.7452 wk Range
42.52Overview - BMY - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
158.89B
P/E (Trailing)
‪13.46‬
P/E (Forward)
‪9.31‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪2.53‬
Price / Book
‪5.59‬
EV / EBITDA
‪8.39‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Short % of Shares Outstanding
‪2.05%‬
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.84%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪64.51‬
200-Day Avg
‪59.40‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 66.21‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BMY - Bristol-Myers Squibb Company
Peers - BMY - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- BMYNYSEBristol-Myers Squibb Co124.91BMarket Cap+26.18%52-week change13.47P/E (Trailing)‪18.87%‬Profit Margin
- LLYNYSEEli Lilly and Company1.05TMarket Cap+38.61%52-week change39.69P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson617.00BMarket Cap+26.51%52-week change29.74P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.464.43BMarket Cap+12.41%52-week change73.62P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.356.01BMarket Cap+38.46%52-week change115.98P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR276.47BMarket Cap+14.68%52-week change21.97P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander, S.A. Sponsored ADR209.19BMarket Cap+28.64%52-week change14.28P/E (Trailing)‪33.46%‬Profit Margin
Profile Summary - BMY - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
